Article

Fft.com on 2020-09-25 01:00

Coronavirus latest: Novavax launches first phase 3 Covid vaccine trial

News, analysis and comment from the Financial Times, the worldʼs leading global business publication

Novavax

Related news

Novavax begins phase 3 trial of flu vaccine candidate thedailyrecord.com
FNovavax launches late-stage Covid vaccine trial in US ft.com
Novavax COVID-19 vaccine enters Phase 3 trial in US, Mexico New York Post
United Kingdom , United States , Mexico
Novavax says Covid-19 vaccine shows 90.4% overall efficacy in US/Mexico Phase 3 trial CNN
United Kingdom , United States , Mexico
Novavax starts final test phase of vaccine The Toledo Blade
Gaithersburg's Novavax begins Phase 1 Ebola vaccine trials bizjournals.com
China , Guinea , Australia , Middle East , Phase 1
MNovavax shares plummet more than 80% after vaccine trial fails marketwatch.com
Novavax to start human trial for ‘ideal’ coronavirus vaccine candidate New York Post
Maryland , Rockville , Gaithersburg
MNovavax starting trial of COVID-19 vaccine in South Africa marketwatch.com
South Africa
FNovavax to complete US vaccine trial enrolment in record time ft.com
Novavax shares jump on positive news of flu vaccine trial bizjournals.com
Novavax kicks off 2019 with positive flu vaccine trial results bizjournals.com
MNovavax stock rises on funding for COVID-19 vaccine trial marketwatch.com
China , Wuhan
FNovavax vaccine trial shows 90% efficacy in combating Covid-19 ft.com
No bonuses for Novavax following failed RSV vaccine trial bizjournals.com
BNovavax Completes Enrollment of U.S.-Based Covid-19 Vaccine Trial barrons.com
South Africa , Mexico , Ducey
UK to offer new vaccine shots to Novavax trial volunteers Seattle Times
United States , Europe , Mexico , England , United Kingdom
PNovavax vaccine up to 96% effective in UK trial pendect.com
United States , United Kingdom